Search results
Results from the WOW.Com Content Network
N-Phenylacetyl-l-prolylglycine ethyl ester is promoted as a nootropic and is a prodrug of cyclic glycine-proline. [a] [2] Other names include the brand name Noopept (Russian: Ноопепт), developmental code GVS-111, and proposed INN omberacetam.
Nootropics (/ n oʊ. ə ˈ t r oʊ p ɪ k s / noh-ə-TROHP-iks or / n oʊ. ə ˈ t r ɒ p ɪ k s / noh-ə-TROP-iks), [1] colloquially brain supplements, smart drugs and cognitive enhancers, are natural, semisynthetic or synthetic compounds which purportedly improve cognitive functions, such as executive functions, attention or memory.
Piracetam is a drug that has efficacy in cognitive disorders, vertigo, cortical myoclonus, dyslexia, and sickle cell anemia; sources differ on its usefulness for dementia. [3] [4] [5] Piracetam is sold as a medication in many European countries.
Get lifestyle news, with the latest style articles, fashion news, recipes, home features, videos and much more for your daily life from AOL.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Nootropil never approved phensuximide: Milontin 1953 [76] [77] pregabalin: Lyrica 30 December 2004 [78] 6 July 2004 [46] [79] 6 July 2004 [79] primidone: Mysoline 8 March 1954 [80] 1952 [46] 1953 [51] rufinamide: Banzel/Inovelon 14 November 2008 [81] [82] sodium valproate: Epilim Unknown December 1977 [51]
This page is a list of Russian drugs, or drugs that were developed in Russia, the former Soviet Union, and/or post-Soviet countries.. Many Russian drugs are indicated for enhancing physical, mental, and/or cognitive performance, including drugs described as nootropics or cognitive enhancers, drugs combatting fatigue, so-called adaptogens or actoprotectors, and others.
UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium.UCB is an international company with revenue of €4.178 billion in 2016 [2] which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. [2]